The global naloxone market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Naloxone is a drug that is used for the treatment of opioid overdose. Opioids are generally used for treating pain, however, opioid-containing drugs are being misused or are being consumed in overdose when patients follow self-medication. The opioid drug class comprises morphine, hydrocodone, oxycodone, heroin, codeine, fentanyl, and methadone. It is also employed as a cough suppressant and in diarrhea treatment. Opioids can be administered either through pills, liquids, intravenous, transdermal patches, or lozenges. Developed nations in North America and Europe have high levels of abuse of this drug. Drugs such as codeine, morphine, fentanyl, and hydrocodone have become a source of addiction, especially among the population, owing to the easy availability of drugs in these regions. According to the National Institute on Drug Abuse, approximately 130 people die every day as a result of opioid abuse in the US alone.
However, global organizations as well as regulatory agencies including the FDA, Centers for Disease Control and Prevention (CDC), and World Health Organization (WHO) are working towards restricting the abuse of opioids by creating awareness and educating prescribers to be cautious while prescribing these drugs. In 2016, the CDC issued guidelines to prescribe opioids, limiting the daily dose of opioids to 90 morphine milligram equivalents (MME). Therefore, such factors are expected to spur the demand for naloxone drugs. This is further likely to augment the global naloxone market growth during the forecast period.
(Get 15% Discount on Buying this Report)
Get Sample Copy of naloxone market at:
https://orionmarketreports.com/request-sample/?id=94055&submit=Request+Sample%0D%0A
Market Coverage
The market number available for – 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Route of Administration
By Distribution Channel
Regions covered-
North America
Europe
Asia-Pacific
Rest of the World
Top Major Key Players:
Pfizer Inc., Novartis International AG, and Mylan NV, among others.
Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?
A full report of naloxone market is available at:
https://orionmarketreports.com/global-naloxone-market/94055/
Global Naloxone Market Report by Segment
By Route of Administration
Oral
Injectable
Nasal
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
